📰 Alkermes News
Page 48 - Alkermes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alkermes. Real-time updates on events, politics, business and more.
November 28, 2022
Mood stabilizers, particularly lithium, are tied to lower mortality rates, including suicide and naturally occurring death, in patients with bipolar disorder.
November 25, 2022
Substance Abuse Treatment Market is set to Garner Staggering Revenues by 2031, TMR Study
November 24, 2022
Addiction Treatment Market to Reach a Value of ~US$ 12 Bn by the of 2030 | Transparency Market Research
November 24, 2022
Substance Abuse Treatment Market is set to Garner Staggering Revenues by 2031, TMR Study
November 23, 2022
High Potency Active Pharmaceutical Ingredient (HPAPI) Market to Grow at a CAGR of 8.7% During 2019 – 2027
November 22, 2022
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx...
November 22, 2022
DUBLIN, Nov. 22, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference on
November 22, 2022
High Potency Active Pharmaceutical Ingredient (HPAPI) Market to Grow at a CAGR of 8.7% During 2019 – 2027
November 22, 2022
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx...
November 19, 2022
Advisors Asset Management Inc. purchased a new stake in shares of Alkermes plc (NASDAQ:ALKS – Get Rating) in the 2nd quarter, HoldingsChannel reports. The institutional investor purchased 18,852 shares of the company’s stock, valued at approximately $562,000. Other institutional investors have also made changes to their positions in the company. Steward Partners Investment Advisory LLC […]